true
Products

BD™ Bruker MALDI Biotyper® CA System.

High throughput capability and extensive library for fast, robust, and reliable identification of microorganisms using MALDI-TOF technology.1-4

Contact Us
BD-Bruker-MALDI-Biotyper-using-MALDI-TOF-technology
Loading
Contact Now

The BD™ Bruker MALDI Biotyper® CA System* 

identifies microorganisms using MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) mass spectrometry to measure a unique proteomic fingerprint of an organism.

It offers a comprehensive FDA-cleared library and straightforward result interpretation designed for fast, accurate and reliable microorganism identification within minutes.2-4

Fully traceable, streamlined workflow

The BD™ Bruker MALDI Biotyper® CA System workflow has been designed to be efficient and easy. The fully traceable workflow has been streamlined and requires only a few simple steps to generate high quality microorganism identifications.2

 

Typically, no more than an isolated single colony from a culture is required. The entire process needs only a few minutes to complete.2

 

The dedicated BD™ Bruker MALDI Biotyper® CA System software automates the process of acquiring the mass spectrum and performing the match against the extensive FDA-cleared reference library to provide a result.

 

The result for each sample is clearly listed within the user interface and interpreted with the resulting confidence score and ‘traffic light’ color scheme, allowing for simple result interpretation.

<h3><b>Robust identification and comprehensive coverage</b></h3>

Robust identification and comprehensive coverage

The BD™ Bruker MALDI Biotyper® CA System offers high accuracy of organism identification, with high-confidence ID results having comparable accuracy to 16S rRNA gene sequencing.5

We have an intentional focus on library expansion which currently offers US-IVD identification for over 480 different FDA-cleared species including gram-negative bacteria, gram-positive bacteria, and yeasts.

The proprietary lifetime** Smartbeam™ laser and high-performance vacuum of the BD™ Bruker MALDI Biotyper® CA System help generate fast target exchange times.

<h3><b>Optimized workflow and efficient testing</b></h3>

Optimized workflow and efficient testing

The MBT Biotarget™ plates can support up to 96 sample positions and can be reused if not all target positions have been consumed, allowing for test volume flexibility and eliminating batching requirements. In addition, routine specimens and positive blood culture specimens can be combined in one run with all results visible in a single final report, which may further help laboratories to save on time and costs.1,5,6

 

For added convenience, BD provides ready-to-use packaged quality controls (Bacterial Test Standard) which have been specifically designed for use with the MALDI Biotyper® and cover the entire mass range of proteins used for precise identification.

<h3><b>Rapid microbial identification directly from positive blood culture</b></h3>

Rapid microbial identification directly from positive blood culture

A fast and reliable diagnosis is critical for patients with bloodstream infections and sepsis.

In combination with the BD™ Bruker MALDI Biotyper® CA System, the MBT Sepsityper® IVD Kit enables rapid and easy identification directly from positive blood cultures, with results available in under 30 minutes.3

<h3><b>Robust, customizable data management</b></h3>

Robust, customizable data management

Monitoring, analyzing and communicating microbiology data in a timely manner can directly impact patient care. However, obtaining, organizing and communicating this information is labor intensive.7,8 To provide timely, optimized care and pursue consistent data-driven improvements to emerging antimicrobial resistance and healthcare-associated infections, clinicians need rapid, real-time access to relevant diagnostic data.9

The BD EpiCenter™ Microbiology Data Management System supports MALDI plate mapping and enables connectivity and automatic transfer of results to the BD Phoenix™ M50 Automated Microbiology System.10

Resources
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
true
References
false
Related products

Contact Us 

Related Solutions
Pagination Left Icon
Pagination Right Icon
Bloodstream infection (BSI) header of medical professionals looking at blood culture results

Bloodstream Infection

Learn more
A BD Clinical Specialists in hospital lab identifying the root cause of issues and inefficiencies along the diagnostic pathway

BD Clinical and Lab Support

Learn more
Notes

*The BD™ Bruker MALDI Biotyper® CA System can only be sold in the US and Puerto Rico. The BD™ Bruker MALDI Biotyper® CA System is also available in Research Use Only (RUO), General Purpose (GP) and IVD CE labels. Please contact your local representative for availability in your country.

** Lifetime means: 500 million laser shots or seven years (whichever occurs first).

 
  1. BD™ Bruker MALDI Biotyper CA System User Manual (8603291)
  2. Saffert RT et al. J Clin Microbiol. 2011;49(3):887–92
  3. Knabl L et al. Lett Appl Microbiol. 2021;73(1):2–8
  4. Watanabe N et al. J Infect Chemother. 2022;28(4):563–8
  5. Cherkaoui A et al. J Clin Microbiol. 2010;48(4):1169–75
  6. Tan KE et al. J Clin Microbiol. 2012;50(10):3301–8
  7. CDC. Preventing Adult Blood Culture Contamination: A Quality Tool for Clinical Laboratory Professionals. Available at: https://www.cdc.gov/labquality/docs/BCC-Prevention_A-Quality-Tool_CDC.pdf. Accessed October 2023
  8. Khare R et al. Clin Infect Dis. 2020;70(2):262–8
  9. Haque M et al. Risk Manag Healthc Policy. 2020;13:1765–80
  10. BD EpiCenter™ Microbiology Data Management System User's Training Manual (SHQ-TM-020)
  11. BD Phoenix™ M50 Automated Microbiology System User's Manual (500008930)
  12. Carey RB et al. Failure of Automated Systems to Detect Vancomycin-Resistant Staphylococcus aureus. Abstract presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2004
  13. Tenover FC et al. Emerg Infect Dis. 2006;12(8):1209–13
  14. Kulah C et al. BMC Infect Dis. 2009;9:30
  15. Mittman SA et al. J Clin Microbiol. 2009;47(11):3557–61
  16. Woodford N et al. J Clin Microbiol. 2010;48(8):2999–3002
  17. Accelerate PhenoTest BC kit Instructions for Use (LBL000172)
  18. BD Synapsys™ Microbiology Informatics Solution User's Manual (L011216)
true